Sarah Cannon Research Institute at TriStar Health

3322 West End Avenue
Nashville, Tennessee 37203

We've found

1 trials

at this facility

JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!